Peroxisome Proliferator-Activated Receptor α Regulates a MicroRNA-Mediated Signaling Cascade Responsible for Hepatocellular Proliferation

Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue MCB About MCB Subscribers Authors Reviewers Advertisers Inquiries from...

Full description

Saved in:
Bibliographic Details
Published inMolecular and Cellular Biology Vol. 27; no. 12; pp. 4238 - 4247
Main Authors Shah, Yatrik M., Morimura, Keiichirou, Yang, Qian, Tanabe, Tomotaka, Takagi, Mitsuhiro, Gonzalez, Frank J.
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.06.2007
Taylor & Francis
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue MCB About MCB Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy MCB RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0270-7306 Online ISSN: 1098-5549 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to MCB .asm.org, visit: MCB       
AbstractList Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue MCB About MCB Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy MCB RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0270-7306 Online ISSN: 1098-5549 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to MCB .asm.org, visit: MCB       
Activation of peroxisome proliferator-activated receptor α (PPARα) leads to hepatocellular proliferation and liver carcinomas. The early events mediating these effects are unknown. A novel mechanism by which PPARα regulates gene expression and hepatocellular proliferation was uncovered. MicroRNA (miRNA) expression profiling demonstrated that activated PPARα was a major regulator of hepatic miRNA expression. Of particular interest, let-7C, an miRNA important in cell growth, was inhibited following 4-h treatment and 2-week and 11-month sustained treatment with the potent PPARα agonist Wy-14,643 in wild-type mice. let-7C was shown to target c-myc via direct interaction with the 3′ untranslated region of c-myc. The PPARα-mediated induction of c-myc via let-7C subsequently increased expression of the oncogenic mir-17-92 cluster; these events did not occur in Ppar α-null mice. Overexpression of let-7C decreased c-myc and mir-17 and suppressed the growth of Hepa-1 cells. Furthermore, using the human PPARα-expressing mouse model, which is responsive to Wy-14,643 effects on β-oxidation and serum triglycerides but resistant to hepatocellular proliferation and tumorigenesis, we demonstrated a critical role for let-7C in liver oncogenesis. Wy-14,643 treatment did not inhibit let-7C or induce c-myc and mir-17 expression. These observations reveal a let-7C signaling cascade critical for PPARα agonist-induced liver proliferation and tumorigenesis.
Activation of peroxisome proliferator-activated receptor α (PPARα) leads to hepatocellular proliferation and liver carcinomas. The early events mediating these effects are unknown. A novel mechanism by which PPARα regulates gene expression and hepatocellular proliferation was uncovered. MicroRNA (miRNA) expression profiling demonstrated that activated PPARα was a major regulator of hepatic miRNA expression. Of particular interest, let-7C, an miRNA important in cell growth, was inhibited following 4-h treatment and 2-week and 11-month sustained treatment with the potent PPARα agonist Wy-14,643 in wild-type mice. let-7C was shown to target c- myc via direct interaction with the 3′ untranslated region of c- myc . The PPARα-mediated induction of c- myc via let-7C subsequently increased expression of the oncogenic mir-17-92 cluster; these events did not occur in Ppar α-null mice. Overexpression of let-7C decreased c- myc and mir-17 and suppressed the growth of Hepa-1 cells. Furthermore, using the human PPARα-expressing mouse model, which is responsive to Wy-14,643 effects on β-oxidation and serum triglycerides but resistant to hepatocellular proliferation and tumorigenesis, we demonstrated a critical role for let-7C in liver oncogenesis. Wy-14,643 treatment did not inhibit let-7C or induce c- myc and mir-17 expression. These observations reveal a let-7C signaling cascade critical for PPARα agonist-induced liver proliferation and tumorigenesis.
Activation of peroxisome proliferator-activated receptor alpha (PPAR alpha ) leads to hepatocellular proliferation and liver carcinomas. The early events mediating these effects are unknown. A novel mechanism by which PPAR alpha regulates gene expression and hepatocellular proliferation was uncovered. MicroRNA (miRNA) expression profiling demonstrated that activated PPAR alpha was a major regulator of hepatic miRNA expression. Of particular interest, let-7C, an miRNA important in cell growth, was inhibited following 4-h treatment and 2-week and 11-month sustained treatment with the potent PPAR alpha agonist Wy-14,643 in wild-type mice. let-7C was shown to target c-myc via direct interaction with the 3' untranslated region of c-myc. The PPAR alpha -mediated induction of c-myc via let-7C subsequently increased expression of the oncogenic mir-17-92 cluster; these events did not occur in Ppar alpha -null mice. Overexpression of let-7C decreased c-myc and mir-17 and suppressed the growth of Hepa-1 cells. Furthermore, using the human PPAR alpha -expressing mouse model, which is responsive to Wy-14,643 effects on {szligbeta}-oxidation and serum triglycerides but resistant to hepatocellular proliferation and tumorigenesis, we demonstrated a critical role for let-7C in liver oncogenesis. Wy-14,643 treatment did not inhibit let-7C or induce c-myc and mir-17 expression. These observations reveal a let-7C signaling cascade critical for PPAR alpha agonist-induced liver proliferation and tumorigenesis.
Activation of peroxisome proliferator-activated receptor alpha (PPARalpha) leads to hepatocellular proliferation and liver carcinomas. The early events mediating these effects are unknown. A novel mechanism by which PPARalpha regulates gene expression and hepatocellular proliferation was uncovered. MicroRNA (miRNA) expression profiling demonstrated that activated PPARalpha was a major regulator of hepatic miRNA expression. Of particular interest, let-7C, an miRNA important in cell growth, was inhibited following 4-h treatment and 2-week and 11-month sustained treatment with the potent PPARalpha agonist Wy-14,643 in wild-type mice. let-7C was shown to target c-myc via direct interaction with the 3' untranslated region of c-myc. The PPARalpha-mediated induction of c-myc via let-7C subsequently increased expression of the oncogenic mir-17-92 cluster; these events did not occur in Pparalpha-null mice. Overexpression of let-7C decreased c-myc and mir-17 and suppressed the growth of Hepa-1 cells. Furthermore, using the human PPARalpha-expressing mouse model, which is responsive to Wy-14,643 effects on beta-oxidation and serum triglycerides but resistant to hepatocellular proliferation and tumorigenesis, we demonstrated a critical role for let-7C in liver oncogenesis. Wy-14,643 treatment did not inhibit let-7C or induce c-myc and mir-17 expression. These observations reveal a let-7C signaling cascade critical for PPARalpha agonist-induced liver proliferation and tumorigenesis.
Author Tomotaka Tanabe
Mitsuhiro Takagi
Qian Yang
Yatrik M. Shah
Keiichirou Morimura
Frank J. Gonzalez
AuthorAffiliation Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
AuthorAffiliation_xml – name: Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Author_xml – sequence: 1
  givenname: Yatrik M.
  surname: Shah
  fullname: Shah, Yatrik M.
  organization: Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health
– sequence: 2
  givenname: Keiichirou
  surname: Morimura
  fullname: Morimura, Keiichirou
  organization: Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health
– sequence: 3
  givenname: Qian
  surname: Yang
  fullname: Yang, Qian
  organization: Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health
– sequence: 4
  givenname: Tomotaka
  surname: Tanabe
  fullname: Tanabe, Tomotaka
  organization: Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health
– sequence: 5
  givenname: Mitsuhiro
  surname: Takagi
  fullname: Takagi, Mitsuhiro
  organization: Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health
– sequence: 6
  givenname: Frank J.
  surname: Gonzalez
  fullname: Gonzalez, Frank J.
  email: fjgonz@helix.nih.gov
  organization: Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health
BackLink https://www.ncbi.nlm.nih.gov/pubmed/17438130$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1u1DAQxy1URLeFG2cUceBEytjO5wVpWVGK1IWqwNmaOJOsUWJv7Ww_XoG34UV4JrzdFZQDJ1vjn39jz_-IHVhnibHnHE44F9Wb5eLdCYDkZQrlIzbjUFdpnmf1AZuBKCEtJRSH7CiE7wBQ1CCfsENeZrLiEmbsxwV5d2uCGym58G4wHXmcnE_nejLXOFGbXJKmdSwlv37Gfb8ZYjUkmCyN9u7y0zxdUmvuyS-mtzgY2ycLDBpbinxYOxtMM1DSRcUZraNd0zBEjX_Q0Tj7lD3ucAj0bL8es2-n778uztLzzx8-Lubnqc4ln1IBFW-pqjl0KLo2F7pr8lggaHMtizrHRpR5W8uqAWwISyEyWRcNzyBDjZU8Zm933vWmGanVZCePg1p7M6K_Uw6N-vfEmpXq3bXi9XaCIgpe7QXeXW0oTGo0YfsntOQ2IXJFkYGQEXy9A-OgQvDU_WnCQW3DUzE8dR-egjLiLx4-7C-8TysC5Q4wNg5zxBvnh1ZNeDc433m02gQl_6N-ubu5Mv3qxnhSGEY16kaJUnGhMiEr-Rv_i7ko
CitedBy_id crossref_primary_10_1016_j_bbadis_2021_166083
crossref_primary_10_3389_fmed_2022_1060244
crossref_primary_10_1007_s10620_018_5242_x
crossref_primary_10_1289_ehp_1002114
crossref_primary_10_1002_rmv_1850
crossref_primary_10_1016_j_yexmp_2021_104723
crossref_primary_10_1016_j_pharmthera_2011_04_009
crossref_primary_10_1093_toxsci_kfx191
crossref_primary_10_1517_14728220903018965
crossref_primary_10_1073_pnas_0813121106
crossref_primary_10_1007_s00204_010_0572_2
crossref_primary_10_1155_2008_759716
crossref_primary_10_1155_2012_605302
crossref_primary_10_1371_journal_pone_0070675
crossref_primary_10_1155_2012_201284
crossref_primary_10_1080_10590501_2010_481477
crossref_primary_10_3390_metabo13080936
crossref_primary_10_1007_s00204_017_2094_7
crossref_primary_10_1093_toxsci_kfs170
crossref_primary_10_1038_leu_2014_10
crossref_primary_10_1002_hep_27744
crossref_primary_10_1016_j_bbagrm_2016_03_002
crossref_primary_10_1016_j_biochi_2013_11_011
crossref_primary_10_1208_s12248_009_9159_3
crossref_primary_10_1002_bies_201200157
crossref_primary_10_1093_toxsci_kfr075
crossref_primary_10_1002_jbt_20325
crossref_primary_10_1155_2017_7058424
crossref_primary_10_1002_jat_3571
crossref_primary_10_1016_j_febslet_2014_03_033
crossref_primary_10_1111_hepr_12386
crossref_primary_10_4049_jimmunol_1201920
crossref_primary_10_1016_j_jhep_2014_10_039
crossref_primary_10_1186_s12943_018_0838_5
crossref_primary_10_1016_j_jmgm_2014_04_006
crossref_primary_10_1093_toxsci_kfn033
crossref_primary_10_1177_0192623308315672
crossref_primary_10_1158_2159_8290_CD_11_0219
crossref_primary_10_1021_pr500641b
crossref_primary_10_3390_ijms22030995
crossref_primary_10_1016_j_bbamcr_2014_03_003
crossref_primary_10_1111_j_1582_4934_2012_01572_x
crossref_primary_10_1016_j_mce_2012_06_025
crossref_primary_10_1080_00498250903098184
crossref_primary_10_1016_j_etp_2008_09_002
crossref_primary_10_1016_j_toxlet_2010_06_019
crossref_primary_10_3727_105221614X13919976902219
crossref_primary_10_1093_toxsci_kfab068
crossref_primary_10_1097_FJC_0000000000000580
crossref_primary_10_1093_toxsci_kfab067
crossref_primary_10_3389_fphar_2023_1184794
crossref_primary_10_3389_fmicb_2014_00102
crossref_primary_10_1016_j_tox_2011_12_014
crossref_primary_10_1016_j_toxlet_2010_10_013
crossref_primary_10_1016_j_tox_2011_12_015
crossref_primary_10_1152_physiolgenomics_00148_2010
crossref_primary_10_1007_s11427_012_4384_x
crossref_primary_10_1016_j_isci_2022_104196
crossref_primary_10_1111_j_1440_1746_2010_06512_x
crossref_primary_10_1186_1477_7827_9_126
crossref_primary_10_1093_toxsci_kfn025
crossref_primary_10_1097_TP_0000000000003675
crossref_primary_10_1186_s41544_020_00051_4
crossref_primary_10_1371_journal_pone_0031433
crossref_primary_10_1038_s41467_020_19554_7
crossref_primary_10_1002_mnfr_201600943
crossref_primary_10_1186_1471_2164_13_729
crossref_primary_10_1016_j_fct_2017_10_026
crossref_primary_10_1186_s12864_017_4096_5
crossref_primary_10_1016_j_pharmthera_2017_05_011
crossref_primary_10_1007_s11095_011_0473_y
crossref_primary_10_1210_er_2018_00064
crossref_primary_10_1093_toxsci_kfm270
crossref_primary_10_1074_jbc_M116_714014
crossref_primary_10_3390_cells12010130
crossref_primary_10_1621_nrs_08002
crossref_primary_10_1155_2010_542359
crossref_primary_10_1016_j_bbrc_2010_05_053
crossref_primary_10_1093_toxsci_kfr168
crossref_primary_10_1016_j_bbagrm_2016_04_002
crossref_primary_10_1016_j_bbamcr_2010_03_013
crossref_primary_10_3724_SP_J_1008_2008_00561
crossref_primary_10_1016_j_bbrc_2023_01_071
crossref_primary_10_1016_j_tox_2008_09_002
crossref_primary_10_1002_ptr_2616
crossref_primary_10_1080_26896583_2024_2327969
crossref_primary_10_1155_2010_814609
crossref_primary_10_1093_mutage_gev036
crossref_primary_10_1016_j_tiv_2023_105577
crossref_primary_10_1152_physiolgenomics_00156_2009
crossref_primary_10_1053_j_gastro_2011_03_058
crossref_primary_10_18632_oncotarget_3531
crossref_primary_10_1016_j_bbamcr_2014_11_017
crossref_primary_10_1186_2045_3701_1_31
crossref_primary_10_1007_s00467_013_2599_0
crossref_primary_10_1146_annurev_pathol_4_110807_092222
crossref_primary_10_1152_ajplung_00201_2010
crossref_primary_10_1016_j_celrep_2021_109506
crossref_primary_10_5582_bst_2019_01109
crossref_primary_10_1039_C3TX50110H
crossref_primary_10_1093_toxsci_kfm255
crossref_primary_10_1155_2012_757803
crossref_primary_10_3390_cancers13092153
crossref_primary_10_15252_emmm_201505384
crossref_primary_10_1186_1752_0509_6_61
crossref_primary_10_1002_path_5201
crossref_primary_10_3390_cancers13030514
crossref_primary_10_1248_yakushi_23_00176
crossref_primary_10_1016_j_mrgentox_2014_01_010
crossref_primary_10_1517_17425255_2013_783817
crossref_primary_10_1096_fj_11_194019
crossref_primary_10_2903_j_efsa_2020_6223
crossref_primary_10_3748_wjg_14_1670
crossref_primary_10_1093_carcin_bgt067
crossref_primary_10_1016_j_toxrep_2020_06_006
crossref_primary_10_1016_j_febslet_2011_07_016
crossref_primary_10_1016_j_mrrev_2011_12_004
crossref_primary_10_1002_hep_22326
crossref_primary_10_1016_j_plipres_2013_12_001
crossref_primary_10_1146_annurev_pharmtox_011112_140250
crossref_primary_10_1155_2008_102737
crossref_primary_10_1124_dmd_122_000908
crossref_primary_10_1371_journal_pone_0071115
crossref_primary_10_1074_jbc_M109_081554
crossref_primary_10_3390_ijms19071907
crossref_primary_10_1016_j_cca_2015_03_006
crossref_primary_10_1007_s12253_016_0136_8
crossref_primary_10_1016_j_envpol_2018_10_061
crossref_primary_10_1016_j_jhep_2013_09_024
crossref_primary_10_1517_17425250903307448
crossref_primary_10_1007_s11859_013_0886_z
crossref_primary_10_2133_dmpk_DMPK_13_RG_114
crossref_primary_10_1016_j_cbi_2013_06_008
crossref_primary_10_1289_ehp_0901217
crossref_primary_10_1002_dvdy_22247
crossref_primary_10_1016_j_bbrc_2023_03_051
crossref_primary_10_1007_s00204_014_1314_7
crossref_primary_10_1016_j_exger_2009_12_009
crossref_primary_10_1002_ijc_25336
crossref_primary_10_1038_nrc3214
crossref_primary_10_1016_j_molmed_2008_07_001
crossref_primary_10_1016_j_critrevonc_2010_01_013
crossref_primary_10_1016_j_toxlet_2014_04_015
crossref_primary_10_1016_j_tox_2007_09_030
crossref_primary_10_1155_2008_103167
crossref_primary_10_1155_2016_7403230
crossref_primary_10_1016_j_cotox_2017_08_004
crossref_primary_10_1539_joh_L7105
crossref_primary_10_1093_toxsci_kfs318
crossref_primary_10_1016_j_ejphar_2015_09_027
crossref_primary_10_1155_2011_629728
crossref_primary_10_1093_toxsci_kfq259
crossref_primary_10_3892_ol_2015_3759
crossref_primary_10_1016_j_mehy_2012_10_017
crossref_primary_10_1038_s41598_017_18529_x
crossref_primary_10_1093_nar_gkp638
crossref_primary_10_1093_toxsci_kfm206
crossref_primary_10_1155_2010_681963
crossref_primary_10_1155_2013_924206
crossref_primary_10_3390_ijms22084173
crossref_primary_10_3389_fgene_2018_00022
crossref_primary_10_1093_toxsci_kfs302
crossref_primary_10_3892_etm_2011_288
crossref_primary_10_1002_hep_30530
crossref_primary_10_1016_j_semcancer_2020_12_007
crossref_primary_10_1016_j_omtn_2017_09_008
crossref_primary_10_1016_j_taap_2021_115644
crossref_primary_10_1152_ajpendo_00175_2013
crossref_primary_10_1523_JNEUROSCI_0780_10_2010
crossref_primary_10_1124_dmd_121_000454
crossref_primary_10_1016_j_toxrep_2015_04_002
crossref_primary_10_1152_physrev_00006_2010
crossref_primary_10_2131_jts_45_449
crossref_primary_10_1093_toxsci_kfq118
crossref_primary_10_1016_j_fct_2017_05_013
crossref_primary_10_1016_j_mrfmmm_2011_05_007
crossref_primary_10_2217_epi_09_17
crossref_primary_10_1177_0192623309336152
crossref_primary_10_1093_toxsci_kfy185
crossref_primary_10_1002_hep_25645
crossref_primary_10_1517_17425255_2012_673587
crossref_primary_10_1016_j_mrgentox_2017_05_011
crossref_primary_10_1111_hepr_12571
crossref_primary_10_1093_nar_gkn567
crossref_primary_10_1053_j_gastro_2008_11_028
crossref_primary_10_1093_toxsci_kfn062
crossref_primary_10_1242_bio_20134507
crossref_primary_10_1016_j_tox_2007_12_030
crossref_primary_10_1016_j_clinbiochem_2024_110707
crossref_primary_10_1155_2008_906542
crossref_primary_10_4254_wjh_v7_i11_1530
crossref_primary_10_1126_scisignal_284pe52
crossref_primary_10_1007_s12010_019_03174_z
crossref_primary_10_1111_bph_13336
crossref_primary_10_3109_10408444_2013_835784
crossref_primary_10_1016_j_febslet_2010_08_009
crossref_primary_10_1093_toxsci_kfq338
Cites_doi 10.1038/nature03552
10.1128/MCB.15.6.3012
10.1073/pnas.0500613102
10.1186/gb-2003-4-10-r69
10.1261/rna.7135204
10.1073/pnas.0307323101
10.1016/S0027-5107(99)00234-1
10.1038/327293a0
10.1002/gcc.2870020212
10.1111/j.1365-2184.1994.tb01424.x
10.1101/sqb.2005.70.044
10.1038/nature03988
10.1016/S0092-8674(04)00045-5
10.1038/nature03677
10.1093/carcin/bgi329
10.1158/0008-5472.CAN-04-0322
10.1038/ng1855
10.1016/j.cell.2005.01.014
10.2165/00129784-200101060-00005
10.1093/carcin/18.11.2029
10.1038/nmeth954
10.1042/bse0400089
10.1038/nature03120
10.1093/emboj/cdf476
10.1073/pnas.242606799
10.1080/01926230309753
10.1111/j.1749-6632.1996.tb18646.x
10.1101/gad.1184404
10.1152/physrev.00025.2005
10.1073/pnas.0508448102
10.1016/j.molcel.2006.11.022
10.1016/S0960-9822(02)00809-6
10.1016/S0006-291X(05)80865-4
10.1158/0008-5472.CAN-04-0637
10.1101/gad.1399806
10.1016/j.molcel.2004.07.007
10.1073/pnas.0510928103
10.1007/s00335-006-0007-9
10.1007/s00109-005-0678-9
10.1080/10915810500208264
10.1073/pnas.0602831103
10.1038/sj.onc.1207111
10.1126/science.1102513
10.1038/nature03817
10.1016/j.cell.2005.07.031
10.4161/cc.2.4.428
10.1080/10915810500210278
10.1093/jnci/90.22.1702
10.1016/S0092-8674(01)00616-X
10.1038/283397a0
10.1056/NEJM198809013190901
10.1177/096032719401300201
10.1016/S0092-8674(03)01018-3
10.1080/10915810500208199
10.1038/ng1901
10.1158/0008-5472.CAN-05-2352
ContentType Journal Article
Copyright Copyright © 2007 American Society for Microbiology 2007
Copyright © 2007, American Society for Microbiology 2007
Copyright_xml – notice: Copyright © 2007 American Society for Microbiology 2007
– notice: Copyright © 2007, American Society for Microbiology 2007
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TM
5PM
DOI 10.1128/MCB.00317-07
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Nucleic Acids Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Nucleic Acids Abstracts
DatabaseTitleList


Nucleic Acids Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1098-5549
EndPage 4247
ExternalDocumentID 10_1128_MCB_00317_07
17438130
12270711
mcb_27_12_4238
Genre Article
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Intramural
GrantInformation_xml – fundername: Intramural NIH HHS
GroupedDBID ---
-DZ
-~X
0R~
123
18M
29M
2WC
39C
3O-
4.4
53G
5RE
5VS
9M8
AAPBV
ABPTK
ACGFO
ACKIV
ACNCT
ADBBV
ADIYS
AENEX
AFFNX
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
H13
HH5
HYE
HZ~
IH2
KQ8
L7B
MVM
N9A
O9-
OK1
P2P
RHF
RHI
RNS
RPM
RSF
TFL
TFW
TR2
UCJ
UDS
VQA
W8F
WH7
WOQ
Y6R
ZA5
ZCA
.55
.GJ
ABJNI
ABRLO
ABTAH
AEOZL
AGHSJ
CGR
CUY
CVF
ECM
EIF
EMOBN
F20
M4Z
NPM
TDBHL
WHG
X7M
YYP
ZGI
ZXP
ZY4
AAYXX
CITATION
7TM
5PM
ID FETCH-LOGICAL-c531t-2081de8910fa2fd52cfb5de8e0d5c3695ab275d938b0abea7224396b1404aca83
IEDL.DBID RPM
ISSN 0270-7306
1098-5549
IngestDate Tue Sep 17 21:21:01 EDT 2024
Fri Oct 25 23:47:40 EDT 2024
Thu Sep 12 19:36:31 EDT 2024
Sat Sep 28 07:45:29 EDT 2024
Tue Jun 13 19:25:01 EDT 2023
Wed May 18 15:26:24 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c531t-2081de8910fa2fd52cfb5de8e0d5c3695ab275d938b0abea7224396b1404aca83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Corresponding author. Mailing address: Building 37, Room 3106, National Cancer Institute, Bethesda, MD 20892. Phone: (301) 496-9067. Fax: (301) 496-8419. E-mail: fjgonz@helix.nih.gov
OpenAccessLink https://europepmc.org/articles/pmc1900062?pdf=render
PMID 17438130
PQID 19664023
PQPubID 23462
PageCount 10
ParticipantIDs highwire_asm_mcb_27_12_4238
pubmedcentral_primary_oai_pubmedcentral_nih_gov_1900062
crossref_primary_10_1128_MCB_00317_07
proquest_miscellaneous_19664023
informaworld_taylorfrancis_310_1128_MCB_00317_07
pubmed_primary_17438130
PublicationCentury 2000
PublicationDate 2007-06-01
PublicationDateYYYYMMDD 2007-06-01
PublicationDate_xml – month: 06
  year: 2007
  text: 2007-06-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Molecular and Cellular Biology
PublicationTitleAlternate Mol Cell Biol
PublicationYear 2007
Publisher American Society for Microbiology
Taylor & Francis
Publisher_xml – name: American Society for Microbiology
– name: Taylor & Francis
References 15284456 - Science. 2004 Sep 3;305(5689):1437-41
15738415 - Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3627-32
16495412 - Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4034-9
15951802 - Nature. 2005 Jul 14;436(7048):214-20
7539101 - Mol Cell Biol. 1995 Jun;15(6):3012-22
15766527 - Cell. 2005 Mar 11;120(5):635-47
7857698 - Hum Exp Toxicol. 1994 Nov;13 Suppl 2:S1-117
16510870 - Genes Dev. 2006 Mar 1;20(5):515-24
16731620 - Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8721-6
14973191 - Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004
16257850 - Int J Toxicol. 2005 Sep-Oct;24(5):301-11
15525708 - RNA. 2004 Dec;10(12):1957-66
12434020 - Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15524-9
15014042 - Genes Dev. 2004 Mar 1;18(5):504-11
17019647 - Mamm Genome. 2006 Oct;17(10):1033-41
15260970 - Mol Cell. 2004 Jul 23;15(2):185-97
8532737 - Prog Clin Biol Res. 1995;391:49-70
8993574 - Ann N Y Acad Sci. 1996 Dec 27;804:573-87
12198168 - EMBO J. 2002 Sep 2;21(17):4663-70
15944707 - Nature. 2005 Jun 9;435(7043):828-33
2268348 - Biochem Biophys Res Commun. 1990 Dec 31;173(3):855-61
14519204 - Genome Biol. 2003;4(10):R69
11779458 - Cell. 2001 Dec 28;107(7):823-6
15531877 - Nature. 2004 Nov 11;432(7014):235-40
16260724 - Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16426-31
15172979 - Cancer Res. 2004 Jun 1;64(11):3753-6
12746117 - Toxicol Pathol. 2003 May-Jun;31(3):295-303
15242341 - Essays Biochem. 2004;40:89-104
15944709 - Nature. 2005 Jun 9;435(7043):839-43
14744438 - Cell. 2004 Jan 23;116(2):281-97
16266980 - Cancer Res. 2005 Nov 1;65(21):9628-32
16878133 - Nat Genet. 2006 Sep;38(9):1060-5
16122423 - Cell. 2005 Aug 26;122(4):553-63
16377806 - Carcinogenesis. 2006 May;27(5):1074-80
14728004 - Am J Cardiovasc Drugs. 2001;1(6):455-66
12007417 - Curr Biol. 2002 Apr 30;12(9):735-9
8467484 - Cancer Res. 1993 Apr 15;53(8):1719-23
3587348 - Nature. 1987 May 28-Jun 3;327(6120):293-7
16869784 - Cold Spring Harb Symp Quant Biol. 2005;70:461-7
6766207 - Nature. 1980 Jan 24;283(5745):397-8
17013392 - Nat Genet. 2006 Nov;38(11):1289-97
15172993 - Cancer Res. 2004 Jun 1;64(11):3849-54
16989803 - Dev Biol. 2007 Feb 1;302(1):1-12
10465011 - Cell Prolif. 1994 May;27(5):269-78
2841597 - N Engl J Med. 1988 Sep 1;319(9):525-32
16257851 - Int J Toxicol. 2005 Sep-Oct;24(5):313-25
17331954 - Carcinogenesis. 2007 Jun;28(6):1171-7
16127449 - Nature. 2005 Sep 29;437(7059):759-63
16784027 - Curr Opin Investig Drugs. 2006 Jun;7(6):560-4
14663478 - Oncogene. 2003 Dec 8;22(56):8999-9006
9395198 - Carcinogenesis. 1997 Nov;18(11):2029-33
17060911 - Nat Methods. 2006 Nov;3(11):881-6
14697198 - Cell. 2003 Dec 26;115(7):787-98
12579299 - Int J Oncol. 2003 Mar;22(3):469-80
14573789 - Mol Cancer Res. 2003 Oct;1(12):882-91
10725470 - Mutat Res. 2000 Mar 17;448(2):159-77
2278970 - Genes Chromosomes Cancer. 1990 Jul;2(2):159-62
9827524 - J Natl Cancer Inst. 1998 Nov 18;90(22):1702-9
16257852 - Int J Toxicol. 2005 Sep-Oct;24(5):327-39
16601267 - Physiol Rev. 2006 Apr;86(2):465-514
17218271 - Mol Cell. 2007 Jan 12;25(1):57-70
15976920 - J Mol Med (Berl). 2005 Oct;83(10):774-85
12851485 - Cell Cycle. 2003 Jul-Aug;2(4):333-8
Yang Q. (R58) 2007
Michael M. Z. (R36) 2003; 1
Murakami H. (R39) 1993; 53
R61
R60
R63
R21
R22
Gu J. (R23) 2006; 17
R25
R24
R26
R29
R28
R1
R2
R3
R4
R5
R7
R8
Lee Y. S. (R31) 2006; 7
R9
Cherkaoui Malki M. (R12) 1990; 173
R30
R32
R34
R33
R35
R38
R37
Butterworth B. E. (R6) 1995; 391
Goldsworthy T. L. (R20) 1994; 27
Jonkers I. J. (R27) 2001; 1
R41
R40
R43
R42
R45
R44
R47
R46
R49
R48
Vogelstein B. (R55) 1990; 2
Zhang B. (R62) 2007; 2
Chang F. (R11) 2003; 22
R50
R52
R51
R10
R54
R53
R56
R14
R13
R57
R16
R15
R59
R18
R17
R19
References_xml – ident: R25
  doi: 10.1038/nature03552
– ident: R29
  doi: 10.1128/MCB.15.6.3012
– ident: R18
  doi: 10.1073/pnas.0500613102
– ident: R61
  doi: 10.1186/gb-2003-4-10-r69
– ident: R7
  doi: 10.1261/rna.7135204
– ident: R9
  doi: 10.1073/pnas.0307323101
– ident: R59
  doi: 10.1016/S0027-5107(99)00234-1
– ident: R5
  doi: 10.1038/327293a0
– volume: 2
  start-page: 159
  year: 1990
  ident: R55
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.2870020212
  contributor:
    fullname: Vogelstein B.
– volume: 27
  start-page: 269
  year: 1994
  ident: R20
  publication-title: Cell Prolif.
  doi: 10.1111/j.1365-2184.1994.tb01424.x
  contributor:
    fullname: Goldsworthy T. L.
– ident: R48
  doi: 10.1101/sqb.2005.70.044
– ident: R42
  doi: 10.1038/nature03988
– ident: R4
  doi: 10.1016/S0092-8674(04)00045-5
– volume: 22
  start-page: 469
  year: 2003
  ident: R11
  publication-title: Int. J. Oncol.
  contributor:
    fullname: Chang F.
– ident: R41
  doi: 10.1038/nature03677
– ident: R38
  doi: 10.1093/carcin/bgi329
– ident: R13
  doi: 10.1158/0008-5472.CAN-04-0322
– ident: R16
  doi: 10.1038/ng1855
– ident: R26
  doi: 10.1016/j.cell.2005.01.014
– volume: 1
  start-page: 455
  year: 2001
  ident: R27
  publication-title: Am. J. Cardiovasc. Drugs
  doi: 10.2165/00129784-200101060-00005
  contributor:
    fullname: Jonkers I. J.
– ident: R43
  doi: 10.1093/carcin/18.11.2029
– ident: R49
  doi: 10.1038/nmeth954
– ident: R37
  doi: 10.1042/bse0400089
– ident: R22
  doi: 10.1038/nature03120
– ident: R30
  doi: 10.1093/emboj/cdf476
– volume: 53
  start-page: 1719
  year: 1993
  ident: R39
  publication-title: Cancer Res.
  contributor:
    fullname: Murakami H.
– ident: R8
  doi: 10.1073/pnas.242606799
– ident: R60
  doi: 10.1080/01926230309753
– volume: 2
  start-page: 12
  year: 2007
  ident: R62
  publication-title: Dev. Biol.
  contributor:
    fullname: Zhang B.
– ident: R45
  doi: 10.1111/j.1749-6632.1996.tb18646.x
– ident: R17
  doi: 10.1101/gad.1184404
– ident: R15
  doi: 10.1152/physrev.00025.2005
– ident: R54
  doi: 10.1073/pnas.0508448102
– year: 2007
  ident: R58
  publication-title: Carcinogenesis.
  contributor:
    fullname: Yang Q.
– ident: R19
  doi: 10.1016/j.molcel.2006.11.022
– volume: 391
  start-page: 49
  year: 1995
  ident: R6
  publication-title: Prog. Clin. Biol Res.
  contributor:
    fullname: Butterworth B. E.
– ident: R28
  doi: 10.1016/S0960-9822(02)00809-6
– volume: 173
  start-page: 855
  year: 1990
  ident: R12
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/S0006-291X(05)80865-4
  contributor:
    fullname: Cherkaoui Malki M.
– volume: 7
  start-page: 560
  year: 2006
  ident: R31
  publication-title: Curr. Opin. Investig. Drugs
  contributor:
    fullname: Lee Y. S.
– ident: R50
  doi: 10.1158/0008-5472.CAN-04-0637
– ident: R53
  doi: 10.1101/gad.1399806
– ident: R35
  doi: 10.1016/j.molcel.2004.07.007
– ident: R57
  doi: 10.1073/pnas.0510928103
– volume: 17
  start-page: 1033
  year: 2006
  ident: R23
  publication-title: Mamm. Genome
  doi: 10.1007/s00335-006-0007-9
  contributor:
    fullname: Gu J.
– ident: R44
  doi: 10.1007/s00109-005-0678-9
– ident: R52
  doi: 10.1080/10915810500208264
– ident: R46
  doi: 10.1073/pnas.0602831103
– ident: R14
  doi: 10.1038/sj.onc.1207111
– ident: R33
  doi: 10.1126/science.1102513
– ident: R63
  doi: 10.1038/nature03817
– ident: R3
  doi: 10.1016/j.cell.2005.07.031
– ident: R34
  doi: 10.4161/cc.2.4.428
– ident: R40
  doi: 10.1080/10915810500210278
– ident: R21
  doi: 10.1093/jnci/90.22.1702
– volume: 1
  start-page: 882
  year: 2003
  ident: R36
  publication-title: Mol. Cancer Res.
  contributor:
    fullname: Michael M. Z.
– ident: R1
  doi: 10.1016/S0092-8674(01)00616-X
– ident: R47
  doi: 10.1038/283397a0
– ident: R56
  doi: 10.1056/NEJM198809013190901
– ident: R2
  doi: 10.1177/096032719401300201
– ident: R32
  doi: 10.1016/S0092-8674(03)01018-3
– ident: R51
  doi: 10.1080/10915810500208199
– ident: R10
  doi: 10.1038/ng1901
– ident: R24
  doi: 10.1158/0008-5472.CAN-05-2352
SSID ssj0006903
Score 2.4165287
Snippet Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
Activation of peroxisome proliferator-activated receptor α (PPARα) leads to hepatocellular proliferation and liver carcinomas. The early events mediating these...
Activation of peroxisome proliferator-activated receptor alpha (PPARalpha) leads to hepatocellular proliferation and liver carcinomas. The early events...
Activation of peroxisome proliferator-activated receptor alpha (PPAR alpha ) leads to hepatocellular proliferation and liver carcinomas. The early events...
SourceID pubmedcentral
proquest
crossref
pubmed
informaworld
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 4238
SubjectTerms Animals
Carcinoma, Hepatocellular - etiology
Carcinoma, Hepatocellular - pathology
Carcinoma, Hepatocellular - physiopathology
Cell Line, Tumor
Cell Proliferation
Gene Expression Profiling
Gene Expression Regulation
Genes, Reporter
Liver Neoplasms - etiology
Liver Neoplasms - pathology
Liver Neoplasms - physiopathology
Luciferases - metabolism
Mice
Mice, Knockout
MicroRNAs - metabolism
Models, Genetic
Peroxisome Proliferators - pharmacology
PPAR alpha - genetics
PPAR alpha - metabolism
Proto-Oncogene Proteins c-myc - biosynthesis
Proto-Oncogene Proteins c-myc - genetics
Pyrimidines - pharmacology
Signal Transduction
Title Peroxisome Proliferator-Activated Receptor α Regulates a MicroRNA-Mediated Signaling Cascade Responsible for Hepatocellular Proliferation
URI http://mcb.asm.org/content/27/12/4238.abstract
https://www.tandfonline.com/doi/abs/10.1128/MCB.00317-07
https://www.ncbi.nlm.nih.gov/pubmed/17438130
https://search.proquest.com/docview/19664023
https://pubmed.ncbi.nlm.nih.gov/PMC1900062
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFL1aJyF4QTC-wmD4AR7TOknjOI8lYqpAmcrHpL1ZduxslZakWjoJ_gL_hj_Cb-LaiaGb9sRbGrtJ2nMd3xufnAPwls9zlfE8CiNdYYHCEAtusHDlkmVMa0p1bt8dLk_Y8nT-8Sw924PUvwvjSPuVWk_by2bari8ct3LTVDPPE5utyiKyTpcsnk1gggHqS_Tx9ovlnltWjjMaYivzbPeYz8ri_dRGsX04Z9VCM6tvZfnPu1OSlwm-pV16VwZ6m0i5MzMdP4KHY0pJFsOlP4Y90x7AvcFk8scB3C-8p9sT-LkyV933dd81hqysX09t3DJ7uKiczZnRBPNIs8Fd5Pcv3HZG9aYnkpSWufflZBGWztwDe35dn9ssvj0nhewtzR77j4TbS0PwN5ElznXbzq4NWLLrzhkxGJ7C6fGHb8UyHN0YwgrH6RaHE6a2BmGltYxrncZVrVLcYahOq4TlqVRxluo84YpKZWSGyUGSM2X1e2QlefIM9tuuNS-AmCjRMkrrXDE11xHlimv8SHnO5bw2dQDvPCBiM4huCFesxFwghk7PNBM0C-DQoyVk34imUiLORBQLTBJ5AHQXQLF1j0Dqwa9EJHcf8I0HWSAy9v-Rremue4E3KoaldhLA8wHyfxc2RlEA2Y1g-NvBCnjfbMG4dkLeYxy__O9vHsIDz1-k0SvY315dm9eYJG3VEUw-feZHbmj8ATFiFLY
link.rule.ids 230,315,730,783,787,888,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLVKESobBOUVCtQLWGbGednOcoioBmhGI2il7iw7dtqRmmTUSSX4Bf6GH-GbuHZimFZdsUsyTibJuY7vjU_OQegdT3PFeB6Fka6gQKGABTdQuHJJGdWaEJ3bb4fLBZ2fpp_PsrMdlPlvYRxpv1KrSXvZTNrVheNWrptq6nli02VZRNbpksbTe-g-9FeS-iJ9fABDwecmlmNGQghg6vnuMZ-WxYeJjWP7es7qhTKrcGUZ0NuDkhcKvqVeelcOeptKuTU2HT1Gj8akEs-Gk3-Cdky7jx4MNpM_9tFe4V3dnqKfS3PVfV9tusbgpXXsqY2baA9nlTM6MxpDJmnWsAn__gXLzqrebLDEpeXufV3MwtLZe0DLb6tzm8e357iQG0u0h_Yj5fbSYLgmPIfRru_s7IClu279I4TDM3R69PGkmIejH0NYQU_toUNBcmsAWFLLuNZZXNUqgw2G6KxKaJ5JFbNM5wlXRCojGaQHSU6VVfCRleTJc7Tbdq15ibCJEi2jrM4VVamOCFdcwyrhOZdpbeoAvfeAiPUguyFcuRJzARg6RVMmCAvQgUdLyE0jmkqJmIkoFpAm8gCRbQBF716C1INjiUjuPuChB1kAMvb-yNZ01xsBjyoKxXYSoBcD5P9ObIyiALEbwfC3gZXwvvkLRLaT8h4j-dV_73mI9uYn5bE4_rT4coAeejYjiV6j3f7q2ryBlKlXb10H-QNYuxcX
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3djpQwGG10jT83RldXcdXthV4yFBjacjmik_GHyUTdZO-alpZ1kgUmC5voK_g2vojP5NcCym72yrsByvBzvtLvo4dzEHrF56liPA39UBdQoFDAghsoXLmkjGpNiE7tt8P5mq6O5x9OkpOJ1Zcj7RdqO6vPqlm9_ea4lbuqCEaeWLDJs9A6XdIo2OkyuIluQZ8ldCzUh4cwFH1ucjlixIcgpiPnPeJBnr2Z2Vi2r-isZiizKleWBT0dmEax4CsKptfloVfplJPxafkA3R8SS7zoL-AhumHqfXS7t5r8sY_uZqOz2yP0c2POm-_btqkM3ljXntK4yXZ_UTizM6MxZJNmB6vw71_w29nVmxZLnFv-3uf1ws-dxQe0_LI9tbl8fYoz2VqyPbQfaLdnBsM14RWMeF1jZwgs5XVyRAiJx-h4-e5rtvIHTwa_gN7aQaeCBNcAuKSUUamTqChVAisM0UkR0zSRKmKJTmOuiFRGMkgR4pQqq-IjC8njA7RXN7V5irAJYy3DpEwVVXMdEq64hkXCUy7npSk99HoEROx66Q3hSpaIC8DQqZoyQZiHDke0hGwrURVKREyEkYBUkXuITAEUnXsRUvauJSK-_g-PRpAFIGPvj6xNc9EKeFxRKLhjDz3pIf93YkMUeYhdCoa_DayM9-UtEN1OznuI5mf_vecRurN5uxSf3q8_HqJ7I6GRhM_RXnd-YV5A1tSpl65__AFIthgq
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Peroxisome+Proliferator-Activated+Receptor+alpha+Regulates+a+MicroRNA-Mediated+Signaling+Cascade+Responsible+for+Hepatocellular+Proliferation&rft.jtitle=Molecular+and+cellular+biology&rft.au=Shah%2C+Yatrik+M&rft.au=Morimura%2C+Keiichirou&rft.au=Yang%2C+Qian&rft.au=Tanabe%2C+Tomotaka&rft.date=2007-06-01&rft.issn=0270-7306&rft.eissn=1098-5549&rft.volume=27&rft.issue=12&rft.spage=4238&rft.epage=4247&rft_id=info:doi/10.1128%2FMCB.00317-07&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-7306&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-7306&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-7306&client=summon